189 related articles for article (PubMed ID: 24477682)
1. Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension.
Osmond DA; Zhang S; Pollock JS; Yamamoto T; De Miguel C; Inscho EW
Am J Physiol Renal Physiol; 2014 Mar; 306(6):F619-28. PubMed ID: 24477682
[TBL] [Abstract][Full Text] [Related]
2. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.
Graciano ML; Nishiyama A; Jackson K; Seth DM; Ortiz RM; Prieto-Carrasquero MC; Kobori H; Navar LG
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F161-9. PubMed ID: 17989111
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats.
Giachini FR; Osmond DA; Zhang S; Carneiro FS; Lima VV; Inscho EW; Webb RC; Tostes RC
Clin Sci (Lond); 2010 Apr; 118(7):463-71. PubMed ID: 19811450
[TBL] [Abstract][Full Text] [Related]
4. Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats.
Giachini FR; Leite R; Osmond DA; Lima VV; Inscho EW; Webb RC; Tostes RC
PLoS One; 2014; 9(3):e91890. PubMed ID: 24638017
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.
Guan Z; Giddens MI; Osmond DA; Cook AK; Hobbs JL; Zhang S; Yamamoto T; Pollock JS; Pollock DM; Inscho EW
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F801-7. PubMed ID: 23269644
[TBL] [Abstract][Full Text] [Related]
6. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats.
Wang CT; Chin SY; Navar LG
Am J Physiol Renal Physiol; 2000 Aug; 279(2):F319-25. PubMed ID: 10919852
[TBL] [Abstract][Full Text] [Related]
7. Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.
Guan Z; Fuller BS; Yamamoto T; Cook AK; Pollock JS; Inscho EW
Am J Physiol Renal Physiol; 2010 May; 298(5):F1276-84. PubMed ID: 20200092
[TBL] [Abstract][Full Text] [Related]
8. Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats.
Franco M; Bautista R; Tapia E; Soto V; Santamaría J; Osorio H; Pacheco U; Sánchez-Lozada LG; Kobori H; Navar LG
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1301-9. PubMed ID: 21367914
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.
Jia LX; Qi GM; Liu O; Li TT; Yang M; Cui W; Zhang WM; Qi YF; Du J
Cardiovasc Drugs Ther; 2013 Dec; 27(6):521-30. PubMed ID: 23887740
[TBL] [Abstract][Full Text] [Related]
10. Renovascular remodeling and renal injury after extended angiotensin II infusion.
Casare FA; Thieme K; Costa-Pessoa JM; Rossoni LV; Couto GK; Fernandes FB; Casarini DE; Oliveira-Souza M
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1295-307. PubMed ID: 26962104
[TBL] [Abstract][Full Text] [Related]
11. P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet.
Inscho EW; Cook AK; Clarke A; Zhang S; Guan Z
Hypertension; 2011 Apr; 57(4):780-7. PubMed ID: 21321307
[TBL] [Abstract][Full Text] [Related]
12. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats.
Mori T; Cowley AW
Hypertension; 2004 Apr; 43(4):752-9. PubMed ID: 14981064
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
Vyas SJ; Blaschak CM; Chinoy MR; Jackson EK
Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension.
Stevenson KM; Edgley AJ; Bergström G; Worthy K; Kett MM; Anderson WP
Hypertension; 2000 Nov; 36(5):839-44. PubMed ID: 11082153
[TBL] [Abstract][Full Text] [Related]
15. Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats.
Wang CT; Navar LG; Mitchell KD
J Hypertens; 2003 Feb; 21(2):353-60. PubMed ID: 12569266
[TBL] [Abstract][Full Text] [Related]
16. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
Inscho EW; Imig JD; Deichmann PC; Cook AK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
[TBL] [Abstract][Full Text] [Related]
17. Bosentan prevents preglomerular alterations during angiotensin II hypertension.
Casellas D; Bouriquet N; Herizi A
Hypertension; 1997 Dec; 30(6):1613-20. PubMed ID: 9403591
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat.
Chin SY; Wang CT; Majid DS; Navar LG
Am J Physiol; 1998 May; 274(5):F876-82. PubMed ID: 9612324
[TBL] [Abstract][Full Text] [Related]
19. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
Zhuo J; Ohishi M; Mendelsohn FA
Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
[TBL] [Abstract][Full Text] [Related]
20. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension.
Alexander BT; Cockrell KL; Rinewalt AN; Herrington JN; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1388-92. PubMed ID: 11294758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
